exchanger, "holding out to see the CV test results."
It's a no brainer. The science that is. This of course might seem entirely flippant towards the virus considering that she has taken the world by vengeful storm. And here I am saying that BIT has this.
It's not just a guess. I've tried to put the science into a short cohesive argument. https://hotcopper.com.au/posts/43808854/single But I'll make it in its deductive form here for the short attention span of day traders.
BIT discovered in 2003 that the E Protein of the RNA virus, SARS-CoV-1, enables ion transfer that is essential for viral replication. BIT developed a compound, BIT036, that inhibited the ion channeling of the E Protein, and therefore stopped viral replication in vitro. BIT then focused on HIV (SARS1 was finished) with same ion channel inhibiting technology in HIV, and phase 2 results created a 'vaccine-like" effect for patients. BIT is now testing compounds on CoV-SARS-2. The main difference between SARS 1, and SARS2, is in the S Protein and not the E Protein. Therefore BIT's compounds that worked on SARS1 will work on SARS2.
